Last reviewed · How we verify
QLT0074
At a glance
| Generic name | QLT0074 |
|---|---|
| Sponsor | QLT Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- QLT0074 CI brief — competitive landscape report
- QLT0074 updates RSS · CI watch RSS
- QLT Inc. portfolio CI